Summary & Overview
HCPCS G6057: Phenothiazine Medication Supply/Administration
HCPCS Level II code G6057 denotes Phenothiazine, a medication class used primarily for antipsychotic and antiemetic indications. As an HCPCS Level II drug code, it represents the supply or administration of a phenothiazine agent in outpatient care settings. Nationally, drug-specific HCPCS codes matter for claims adjudication, pricing transparency, and consistent reporting of medication utilization across payers.
Key payers in this overview include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of the code's clinical context, typical sites of service, and the payer landscape relevant to HCPCS drug coding. The publication also summarizes benchmarking considerations, common modifiers when reported, and where clinicians and billing staff typically capture this code on claim forms.
This summary provides practical context for coding teams, revenue cycle managers, and policy analysts seeking a national perspective on phenothiazine reporting under HCPCS Level II, including implications for reimbursement consistency and claims processing. Data not available in the input limits detailed payer-specific rates, utilization metrics, and related diagnosis mappings, which are not included here.
Billing Code Overview
HCPCS Level II code G6057 represents Phenothiazine, a class of antipsychotic/antiemetic medications. The service type for this code is medication administration or drug supply, reflecting provision of the active pharmaceutical ingredient or its administration as captured by an HCPCS Level II drug code. The typical site of service is outpatient clinics, physician offices, and outpatient infusion or injection centers where injectable or infused formulations of phenothiazine-class agents may be administered.
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult or elderly individual being treated for severe nausea, vomiting, agitation, or certain psychiatric conditions where a phenothiazine-class medication is indicated. Phenothiazines are administered in outpatient infusion centers, emergency departments, inpatient hospital floors, or behavioral health units when parenteral or clinic-administered formulation is required. Typical workflow: patient presents with uncontrolled nausea or acute agitation; clinician assesses indications, allergies, and current medications; an order is placed for G6057 (phenothiazine) with dose, route, and frequency; pharmacy prepares the medication; nursing verifies patient identity and administers medication; post-administration monitoring occurs for sedation, hypotension, extrapyramidal symptoms, or cardiac effects; documentation includes indication, dose, route, lot number, modifier TC for technical component when applicable, and patient response.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
TC | Technical component | Use when billing only the technical component of the service (e.g., medication administration supplies billed by facility). |